Nuvo Pharmaceuticals Inc (MRV.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 233 | 313 | 715 | 1,338 | 674 |
| Accounts receivable | 2,775 | -2,065 | 1,696 | -210 | -233 |
| Other Working Capital | -2,493 | -3,341 | 5,513 | 677 | -1,348 |
| Other Operating Activity | 3,353 | -5,539 | -5,284 | -3,540 | -4,168 |
| Operating Cash Flow | $3,868 | $-10,632 | $2,640 | $-1,735 | $-5,075 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -368 | -332 | 154 | -229 | -141 |
| Purchase Of Investment | N/A | N/A | -10,000 | N/A | N/A |
| Sale Of Investment | N/A | N/A | 43,554 | N/A | N/A |
| Other Investing Activity | -8,000 | 10,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-8,368 | $9,668 | $33,708 | $-229 | $-141 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 4,000 |
| Debt Repayment | -55 | N/A | N/A | -1,882 | -1,347 |
| Common Stock Issued | 205 | 96 | 3,026 | 77 | 61 |
| Other Financing Activity | -34,858 | 731 | -3,841 | 4,000 | 0 |
| Financing Cash Flow | $-34,708 | $827 | $-815 | $2,195 | $2,714 |
| Exchange Rate Effect | 117 | 542 | 121 | 241 | -73 |
| Beginning Cash Position | 48,680 | 48,275 | 12,621 | 12,149 | 14,724 |
| End Cash Position | 9,589 | 48,680 | 48,275 | 12,621 | 12,149 |
| Net Cash Flow | $-39,208 | $-137 | $35,533 | $231 | $-2,502 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,868 | -10,632 | 2,640 | -1,735 | -5,075 |
| Capital Expenditure | -368 | -332 | -224 | -229 | -149 |
| Free Cash Flow | 3,500 | -10,964 | 2,416 | -1,964 | -5,224 |